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Abstract: A 31-year old woman, previously fit & well was admitted with pressing retrosternal chest pain and
palpitations of sudden onset. Her body weight was normal (BMI 20.5 kg/m
2) and there was no significant family
history of cardiac disease. She smoked, however, about 15 cigarettes a day and she had been taking combined
oral contraceptive pill (Cilest®) for about three years. On admission she appeared sweaty and in pain, blood
pressure 130/70 mmHg, heart rate about 110/min, mild lid-lag sign. Heart sounds were normal and chest was clear.
ECG revealed 2-3 mm ST segment elevations in II, III, aVF as well as V2 to V5. Troponin I was raised and she was
qualified to an emergency coronary angiography. This revealed a massive spasm of left anterior descending (LAD)
coronary artery that responded to intracoronary glyceryl trinitrite administration, however, with the presence of
critical narrowing of the LAD apical segment with possible superimposed thrombus. Cardiac ultrasound revealed
akinesis of 1/2 of apical area consistent with myocardial infarction
Treatment and progress: She was started on Aspirin, Simvastatin, and Diltiazem, but continued to have persistent
tachycardia and tremor. Thyroid function tests were ordered and showed thyrotoxicosis [free T4-46.9 pmol/l (ref.
range 9-25), free T3-11.9 pmol/l (2-5), TSH - 0.02 mIU/l (0.27-4.2)]. She was referred for an endocrine opinion and
started on Thiamazole. Other investigations revealed elevated anti-TPO and anti-TSH receptor antibodies consistent
with Graves’ disease. Thrombophilia screen was negative. She had remained euthyroid on a “block & replace”
regimen (Thiamazole plus L-Thyroxine) that was discontinued after 18 months. She denies any anginal symptoms,
but continues to smoke against medical advice.
Conclusions: Our case highlights the possibility of development of an acute myocardial infarction in a young
subject with thyrotoxicosis. We speculate that patient’s smoking habit combined with subtle thyrotoxicosis-induced
prothrombotic state and/or coronary-artery spasm had lead to the above-mentioned acute coronary event.
Background
Acute myocardial infarction (MI) can occur in young
subjects, and typical precipitating factors may include
hyperlipidaemias, hypercoagulable states, cocaine abuse
and other factors. According to the US data about 80%
of young subjects are overweight or obese and at least
one the classical cardiovascular risk factors is present in
about 96% of cases [1]. Acute MI is, however, still rela-
tively rare in young women and in a case series of 165
patients admitted with acute MI aged below 45 with
(average age 41.3 ± 4.6 years, range 22-45 years) women
constituted only 16% of cases [1]. We present the case
where acute MI was an initial presentation of thyrotoxi-
cosis in a young women of 31 years of age who had
been entirely fit & well prior to this acute coronary
event.
Case Presentation
A 31-year old woman, previously fit & well was
admitted with a history of sudden onset of pressing ret-
rosternal pain and palpitations. Her body weight was
normal (BMI 20.5 kg/m
2). She had no significant family
history of ischaemic heart disease and had one healthy
child of 5 years of age. She smoked, however, about 15
cigarettes a day and she had been taking Cilest® i.e. a
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of Ethynylestradiol and 0.250 mg Norgestimate, for
about three years prior to her admission. On examina-
tion she was sweaty and in pain, blood pressure 130/70
mmHg, heart rate about 110/min, mild lid-lag sign.
Heart sounds were normal and chest was clear. ECG
(see Figure 1) revealed 2-3 mm ST segment elevations
in II, III, aVF as well as V2 to V5. Initial laboratory tests
revealed normal electrolytes, and clotting screen, normal
Full Blood Count and surprisingly low concentrations of
plasma lipids (total cholesterol - 117 mg/dl, triglycerides
-9 3m g / d l ,L D L - c h o l e s t e r o l-6 1m g / d l ,H D L - c h o l e s -
terol - 37.8 mg/dl). Troponin I levels were, however,
markedly raised (12.2 μg/l) and so she was qualified for
an emergency coronary angiography (presented in Fig-
ure 2). This revealed a massive spasm of left anterior
descending (LAD) coronary artery that responded to
intracoronary glyceryl trinitrite administration, however,
with the presence of critical narrowing of the LAD api-
cal segment with possible superimposed thrombus. Car-
diac ultrasound revealed akinesis of 1/2 of apical area
with hypokinesis of adjacent segments, ejection fraction
38% - Figure 3. The titre of antinuclear antibodies was
normal.
She was started on standard medication used in
patients after myocardial infarction (Aspirin, Clopido-
grel, Heparin, Simvastatin, Diltiazem), but despite this
she was noted to have persistent tachycardia about 100-
110 beats/minute and tremor. On the strength of that
thyroid function tests were requested and revealed thyr-
otoxicosis (see Table 1). She was started on Thiamazole
(Metizol©) 20 mg b.d.and referred for an endocrine
opinion.
In the Endocrine Clinic she was still hyperthyroid with
a thyroid bruit and was clinically diagnosed to have
Graves’disease. Thyroid ultrasound scan showed no focal
lesions. She was subsequently found to have raised both
anti-TSH receptor and anti-thyroid peroxidase antibodies
that was confirmed autoimmune thyrotoxicosis (Table 2).
Further autoimmune screen (also Table 2) revealed no
evidence of thrombophilia. Following normalisation of
free T4 and free T3 she was stabilized on a “block &
replace regimen” (Thiamazole (Metizol©) plus L-thyrox-
ine) that was continued for about 18 months. She cur-
rently remains euthyroid without medication [TSH - 1.39
mIU/l (Ref. 0.27-4.2)], but despite several warnings con-
tinues to smoke about 10 cigarettes a day. Following suc-
cessful treatment of thyrotoxicosis her lipid profile
showed significant rise in cholesterol levels in compari-
son to the thyrotoxic phase suggestive of occult dyslipi-
daemia previously masked by thyrotoxicosis (total
cholesterol - 227 mg/dl, LDL-cholesterol - 164 mg/dl,
HDL-cholesterol - 41 mg/dl, triglycerides - 109 mg/dl).
Discussion
Both hyper- and hypothyroidism are known to be asso-
ciated with coagulation abnormalities. In case of
hypothyrodism the data are somehow conflicting and
Figure 1 Admission ECG of the presented patient with an
acute myocardial infarction and thyrotoxicosis. The tracing
demonstrates 2-3 mm ST segment elevations in II, III, aVF as well as
V2 to V5.
Figure 2 Critical narrowing of left anterior descending artery in
the presented patient close to the apical region with flow
cessation possibly with residual thrombus, no evidence of
significant narrowing in other vessels.
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part, related to the degree hypothyroidism [2]. In brief,
milder forms of hypothyroidism may present with
abnormalities resembling von Willenbrand’sd i s e a s e[ 3 ] ,
i.e. decreased platelet adhesives, abnormal bleeding
times, decreased levels of factors VIII, IX, XI and XII
and a state with low von Willebrandt factor (vWF)
activity [3], while severe hypothyroidism may result in a
hypocoagulable state as shown by increases in platelet
and factor VII as well as by decreases in fibrinolytic
activity [4]. On the other hand there is quite consistent
evidence that thyrotoxicosis is directly associated with
the presence of a prothrombotic state. Horne et al. [5]
demonstrated higher concentrations of prothrombin
fragment 1 + 2, fibrynogen, factor VIII, antithrombin,
tissue plasminogen activator antigen (tPA), plasminogen
activator inhibitor 1 (PAI-1), PAI-1/tPA ratio and C-
reactive protein in subjects with a history of cured thyr-
oid cancer receiving standard TSH-suppressive L-thyr-
oxine therapy in comparison to concentrations of the
above parameters measured in the same subjects in a
hypothyroid phase prior to radioiodine whole-body
scanning procedure. Interestingly, anticoagulative factors,
namely protein C and plasmin-antiplasmin complexes
were also significantly lower during the hyperthyroid per-
iod. Squizzato et al. [6] described increased incidence of
acute cerebral ischaemia in subjects with hyperthyroid-
ism that was independent of thyrotoxic atrial fibrillation
and cardioembolic stroke. More recently Homoncik et al.
[7] have reported raised concentrations of vWF and
increased baseline platelet plug formation in patients
with thyrotoxicosis. These abnormalities were corrected
by treatment of thyrotoxicosis with thiamazole. Also sub-
jects with L-thyroxine-induced thyrotropin suppression
as part of treatment of benign thyroid nodules were
found to have a pro-coagulable profile [8]. In contrast,
subjects with hypothyroidism had lower concentrations
vWF antigen and factor VIII together with longer partial
thromboplastin time (APTT) that was corrected by treat-
ment with L-thyroxine. This might indicate the potential
for increased bleeding tendency in subjects with
hypothyroidism. We speculate whether the above men-
tioned abnormalities may contribute to an increased pre-
valence of menorrhagia typically observed in subjects
with hypothyroidism.
Furthermore, long-term follow-up studies have
revealed increased mortality from cardiovascular and cer-
ebrovascular disease in those with past history of overt
hyperthyroidism [9] as well as in those with subclinical
hyperthyroidism [10]. In another study an elevated serum
fT3 concentration was associated with a 2.6-fold greater
likelihood of the presence of a coronary event [11].
Our subject was a smoker, and so despite a normal
BMI she had a clear risk factor for CV disease i.e. like
96% of young subjects presenting with MI, as described,
by Zarich et al. [1]. Though connective tissue disease
[12] or factor V Leyden mutations and other thrombo-
philias have been linked with acute thrombotic events
[13], we did not find evidence of thrombophilia or con-
nective tissue disease in our subject. Her lipid profile
with low cholesterol levels is likely to be a direct result
of thyrotoxicosis, but one should note that satisfactory
lipid profiles are not uncommon among young subjects
with MI. For instance, Zarich et al. [1] reported LDL
cholesterol levels below 100 mg/dl in 32% of young sub-
jects with acute MI, while Akosah et al. [14] report LDL
Figure 3 Echocardiographic image showing left ventricular wall
motion abnormalities of the apex in systole (arrows): apical
two chamber view (left upper panel), four chamber view (right
upper panel) and three chamber view (left lower panel).
Matching bulls eye display of left ventricular segments strain
quantitative analysis (right lower panel). Reduced myocardial
contraction within the region of myocardial infarction is clearly
visible (blue and pink colour).
Table 1 Selected biochemical results and thyroid function test of the presented 31-year old female patient with an
acute myocardial infarction
Thyroid hormones
Glucose
(mg/dl)
Ref:
60-100
Urea
(mg/dl)
Ref:
20-40
Creatinine
(mg/dl)
Ref:
0.5-1.35
Total cholesterol
(mg/dl)
Triglycerides
(mg/dl)
Free T4 (pmol/l)
Ref:
9-25
Free T3
(pmol/l)
Ref:
2-5
TSH
(mIU/l)
Ref:
0.27-4.2
94 21 0.42 117 93 46.9 11.9 0.02
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young adults with premature heart disease. Though our
subject did use an oral contraceptive pill, we note that
in contrast to increased risk of deep venous thrombosis,
acute MI is actually very rare among the users of oral
contraceptive pill and no evidence of thrombophilia
[15]. In another recent study there was no increase in
the risk of acute MI among 48321 Swedish women aged
30-49 years who used oral contraceptive pill [16]. Cor-
onary artery spasm, also described in our patient, might
be another factor contributing the the development of
an acute myocardial infarction. There are also reports of
severe coronary artery spasm leading to a myocardial
infarction in young subjects with thyrotoxicosis, how-
ever, without classical cardiovascular disease risk factors
[17]. Furthermore coronary artery spasm seems to be
more common in smokers [18], while our patient
smoked about 15 cigarettes a day.
Administration of iodine contrast during coronarogra-
phy was also unlikely to have any adverse effects on
thyroid function as iodine contrasts typically suppress
thyroid hormone release in the short-term (the Wolff-
Chaikoff effect), the phenomenon that is utilized in rapid
preparation for thyroid surgery, or in the treatment of
thyrotoxic storm [19,20]. Only prolonged administration
of iodine compounds may contribute to the develop-
ment of thyrotoxicosis through the so called Wolff-
Chaikoff escape phenomenon [20].
Conclusions
Our case highlights the possibility that thyrotoxicosis
may facilitate development of an acute myocardial
infarction even in a young person without previous his-
tory of thrombosis, vasculitis or heart disease. In our
opinion cigarette smoking combined with a thyrotoxico-
sis-induced prothrombotic state was enough to tip the
balance towards development of acute coronary throm-
bosis and subsequent acute myocardial infarction even
in such a young and not-obese female subject. Our case
therefore highlights the need for awareness of the possi-
bility of such serious complication even among young
subjects with thyrotoxicosis.
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